Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Rimm

Showing results (111-120 of 412) with videos related to

Pageof 42
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2014
In situ tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomasKurt A Schalper, Vamsidhar Velcheti, Daniel Carvajal, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 4, 2005
Detection of malignancy in cytology specimens using spectral-spatial analysisCesar Angeletti, Neal R Harvey, Vitali Khomitch, et al.
Plos One|November 27, 2013
Comparison of HER2 and phospho-HER2 expression between biopsy and resected breast cancer specimens using a quantitative assessment methodYalai Bai, Huan Cheng, Jennifer Bordeaux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2020
PD-L1 Protein Expression on Both Tumor Cells and Macrophages are Associated with Response to Neoadjuvant Durvalumab with Chemotherapy in Triple-negative Breast CancerFahad Shabbir Ahmed, Patricia Gaule, John McGuire, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2021
Programmed Death-Ligand 1 Tumor Proportion Score and Overall Survival From First-Line Pembrolizumab in Patients With Nonsquamous Versus Squamous NSCLCDeborah B Doroshow, Wei Wei, Swati Gupta, et al.
Gynecologic Oncology|February 16, 2017
Objective, domain-specific HER2 measurement in uterine and ovarian serous carcinomas and its clinical significanceDaniel E Carvajal-Hausdorf, Kurt A Schalper, Yalai Bai, et al.
Cancer Research|December 3, 2004
Automated quantitative analysis of HDM2 expression in malignant melanoma shows association with early-stage disease and improved outcomeAaron J Berger, Robert L Camp, Kyle A Divito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Classification of breast cancer using genetic algorithms and tissue microarraysMarisa Dolled-Filhart, Lisa Rydén, Melissa Cregger, et al.
Biotechniques|August 28, 2020
Antibody validation for protein expression on tissue slides: a protocol for immunohistochemistryTyler MacNeil, Ioannis A Vathiotis, Sandra Martinez-Morilla, et al.
The Journal of Biological Chemistry|June 12, 2003
Functional correlates of mutations in beta-catenin exon 3 phosphorylation sitesElayne Provost, Yumi Yamamoto, Isabel Lizardi, et al.
Pageof 42

Showing results (111-120 of 412) with videos related to

Sort By:
Pageof 42
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2014
In situ tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomasKurt A Schalper, Vamsidhar Velcheti, Daniel Carvajal, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 4, 2005
Detection of malignancy in cytology specimens using spectral-spatial analysisCesar Angeletti, Neal R Harvey, Vitali Khomitch, et al.
Plos One|November 27, 2013
Comparison of HER2 and phospho-HER2 expression between biopsy and resected breast cancer specimens using a quantitative assessment methodYalai Bai, Huan Cheng, Jennifer Bordeaux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2020
PD-L1 Protein Expression on Both Tumor Cells and Macrophages are Associated with Response to Neoadjuvant Durvalumab with Chemotherapy in Triple-negative Breast CancerFahad Shabbir Ahmed, Patricia Gaule, John McGuire, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2021
Programmed Death-Ligand 1 Tumor Proportion Score and Overall Survival From First-Line Pembrolizumab in Patients With Nonsquamous Versus Squamous NSCLCDeborah B Doroshow, Wei Wei, Swati Gupta, et al.
Gynecologic Oncology|February 16, 2017
Objective, domain-specific HER2 measurement in uterine and ovarian serous carcinomas and its clinical significanceDaniel E Carvajal-Hausdorf, Kurt A Schalper, Yalai Bai, et al.
Cancer Research|December 3, 2004
Automated quantitative analysis of HDM2 expression in malignant melanoma shows association with early-stage disease and improved outcomeAaron J Berger, Robert L Camp, Kyle A Divito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Classification of breast cancer using genetic algorithms and tissue microarraysMarisa Dolled-Filhart, Lisa Rydén, Melissa Cregger, et al.
Biotechniques|August 28, 2020
Antibody validation for protein expression on tissue slides: a protocol for immunohistochemistryTyler MacNeil, Ioannis A Vathiotis, Sandra Martinez-Morilla, et al.
The Journal of Biological Chemistry|June 12, 2003
Functional correlates of mutations in beta-catenin exon 3 phosphorylation sitesElayne Provost, Yumi Yamamoto, Isabel Lizardi, et al.
Pageof 42